Stevanato Group CFO Dal Lago Marco Buys Company Shares
Dal Lago Marco, CFO at Stevanato Group, purchased 2,356 shares in a recent transaction.
Key Points
- Dal Lago Marco, CFO of Stevanato Group, bought 2,356 shares of STVN on June 12, 2026.
- Stevanato Group's stock traded at $18.39 on Friday, with a market cap of $5.02 billion.
- Analysts recently set new price targets, with TD Cowen initiating a 'buy' rating at $25.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dal Lago Marco, the Chief Financial Officer of Stevanato Group S.p.A. (NYSE: STVN), recently purchased 2,356 shares of the company. This transaction took place on June 12, 2026. The shares were acquired without a specific price being reported, and it was not part of a pre-arranged trading plan.
Insider Buying and Selling at Stevanato Group S.p.A.
In addition to Dal Lago Marco's purchase, other insiders at Stevanato Group have been active. On June 15, 2026, several insiders, including Karen Flynn and William Federici, sold 1,493 shares each at $17.09 per share. William Federici also bought 4,975 shares on June 12, 2026, alongside Dal Lago Marco's purchase.
Stevanato Group S.p.A. Stock Down 12.6%
Shares of NYSE:STVN traded near $18.39 on Friday. Stevanato Group has a market capitalization of approximately $5.02 billion. Its price-to-earnings ratio is 31.7, and it has a forward P/E of 21.9. The company has a beta of 0.776, indicating lower volatility compared to the market. The stock's 52-week range is from $12.89 to $28.00, with a 50-day moving average of $17.39 and a 200-day moving average of $19.57.
$STVN stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a 'buy' rating and a price target of $25. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a 'buy' rating and a $21 target. The consensus among analysts is a 'buy' rating, with a mean price target of $24.45 based on 10 opinions.
About Stevanato Group
Stevanato Group S.p.A. is a global company based in Piombino Dese, Italy. It operates in the healthcare sector, focusing on medical instruments and supplies. The company designs and manufactures products for the biopharma and healthcare industries, offering solutions such as syringes, vials, and diagnostic systems. Founded in 1949, Stevanato Group serves a wide range of clients across the pharmaceutical, biotechnology, and diagnostics sectors.
Bottom Line
The recent insider buying activity by Dal Lago Marco highlights ongoing interest in Stevanato Group's stock at the executive level. Investors often track such insider transactions to gauge confidence in a company's future prospects. It's important to note that these transactions are reported after the fact and may not reflect the insiders' current positions.
Get Stevanato Group S.p.A. alerts
New 13F filings, insider trades, and analyst moves on $STVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.